Beta-blocker therapy is a pharmacological approach widely employed in cardiovascular medicine to manage various conditions. These medications, known as beta-blockers, function by blocking the effects of adrenaline, thus reducing heart rate and blood pressure. Beta blockers have proven efficacy in treating conditions such as hypertension, angina, and certain cardiac arrhythmias. They are also commonly prescribed for heart failure patients to improve cardiac function and reduce symptoms. Moreover, beta-blocker therapy plays a crucial role in post-myocardial infarction care, aiding in preventing secondary cardiovascular events. The versatility of beta blockers extends beyond cardiovascular applications, as they are sometimes used to alleviate symptoms associated with anxiety and migraine headaches. While well-tolerated by many patients, it is essential to consider individual medical histories and potential contraindications when prescribing beta-blocker therapy. As with any medical intervention, close collaboration between healthcare providers and patients ensures the optimal management of cardiovascular health
.
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Analysis of cardiovascular risk factors in patients with type 1 diabetes mellitus
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Beyond PCSK9: The next wave of lipid-lowering and thrombosis prevention - from bench to breakthrough
Narendra Kumar, HeartbeatsZ Academy, United Kingdom